Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Hematology"
DOI: 10.1007/s00277-021-04473-4
Abstract: Despite the clinical value of HMGB1 in non-Hodgkin lymphoma (NHL), the impact of HMGB1 protein expression on survival of patients with mature T-cell and NK-cell lymphoma (T/NK-CL) is unknown. Here, we evaluated correlations of HMGB1… read more here.
Keywords: relapsed refractory; hmgb1 expression; expression; high hmgb1 ... See more keywords